Skip to main content

JOIN AVANCE CLINICAL AT THE WORLD ORPHAN DRUG CONGRESS USA IN BOSTON, 23-25 APRIL 2024 AT BOOTH #730

JOIN AVANCE CLINICAL AT THE WORLD ORPHAN DRUG CONGRESS USA IN BOSTON, 23-25 APRIL 2024 AT BOOTH #730

JOIN AVANCE CLINICAL AT THE WORLD ORPHAN DRUG CONGRESS USA IN BOSTON, 23-25 APRIL 2024 AT BOOTH #730

423 423 people viewed this event.

Avance Clinical is pleased to announce its attendance at the World Orphan Drug Congress USA, set to take place in Boston in 23-25 April 2024. With the successful completion of over 60 clinical trials for rare diseases in the last five years, Avance Clinical is at the forefront of offering innovative solutions to the challenges presented by orphan drug development.

Avance Clinical stands as a leading full-service CRO, specializing in facilitating the clinical trial process for international biotech companies. The organization leverages the advantageous clinical trials environment in North America, reflecting a deep commitment to excellence and innovation in the field of clinical research. With a distinguished record of navigating complex regulatory landscapes and a focus on rare diseases, Avance Clinical is dedicated to advancing research and ensuring faster access to therapies that can make a significant difference in patients’ lives.

Why Choose Avance Clinical for Your Next Rare Disease Trial?

  • Deep Therapeutic Knowledge:
    With over 50 trials in rare and orphan diseases completed globally in the last five years, Avance Clinical boasts an extensive understanding of the unique challenges in managing small patient populations. Their expertise underscores a profound grasp of disease mechanisms essential for effective clinical trial design and management.
  • Patient-Centric Approach:
    Avance Clinical places patients at the heart of their operations, ensuring optimal care through the selection of experienced sites and clinics. The company’s collaborative efforts with advocacy groups and tailored recruitment strategies aim to enhance patient enrollment and retention, ultimately facilitating better access to crucial medicines.
  • Innovative Trial Design & Regulatory Expertise:
    Avance Clinical is adept at crafting adaptive, patient-focused protocols that adhere to regulatory standards. Their innovative approach to study design, combined with over 26 years of experience in delivering FDA and EMA-quality data, positions them as a CRO capable of navigating the complexities of the regulatory landscape efficiently.
  • Data Excellence and Quality Oversight:
    The integrity of data is of utmost importance at Avance Clinical. Through robust data management and real-time endpoint safeguarding, the company guarantees insightful and accurate data, particularly crucial in rare disease trials with limited patient numbers.
  • Global Reach, Local Expertise:
    Avance Clinical merges its global presence with local knowledge, offering seamless coordination across international sites while maintaining an acute understanding of regional regulatory nuances and cultural sensitivities.

Join Avance Clinical at the World Orphan Drug Congress USA to learn more about their comprehensive services and how they can support your next rare disease trial towards achieving groundbreaking success.

About Avance Clinical

Avance Clinical is a full-service CRO for biotechs with a proven track-record for delivering clinical excellence in Australia, New Zealand, and North America. As the largest premium full-service CRO in Australia and North America, Avance Clinical specializes in delivering top-tier clinical trials that yield globally accepted data.

Award-winning CRO for Biotechs

Avance Clinical has been recognized for the fourth consecutive year by Frost & Sullivan in 2023, being awarded the Best Practices Customer Value Leadership for Biotech’s award, for its continuous exceptional performance.

Pre-clinical through to Phase I/II

Avance Clinical offers pre-clinical consultancy services with their experienced ClinicReady team right through to Phase I/II clinical services leveraging significant Government incentive rebates of up to 43.5% and rapid start-up regulatory processes that are available in Australia and highly qualified sites and networks within the United States. With experience across more than 110 therapeutic indications, Avance Clinical can deliver world-class, high-quality, internationally accepted data suitable for FDA and EMA review.

Technology

Avance Clinical uses state-of-the-art technology and gold-standard systems across all functional areas to provide clients with the most effective processes. Medidata, Oracle, Zelta, Veeva and Medrio are just some of Avance Clinical’s technology partners.

www.avancecro.com

To register for this event email your details to marketing@avancecro.com

Register using webmail: Gmail / AOL / Yahoo / Outlook

 

Date And Time

23-04-2024 to
24-04-2024
 

Location

 

Event Types

 

Event Category